首页> 外文期刊>Medical hypotheses >Does an inhibition of the ubiquitin/26S proteasome pathway of protein degradation underlie the pathogenesis of non-familial Alzheimer's disease?
【24h】

Does an inhibition of the ubiquitin/26S proteasome pathway of protein degradation underlie the pathogenesis of non-familial Alzheimer's disease?

机译:抑制泛素/ 26S蛋白酶降解蛋白质的途径是否是非家族性阿尔茨海默氏病发病机理的基础?

获取原文
获取原文并翻译 | 示例
           

摘要

The ubiquitin/26S proteasome pathway catalyses the degradation of key regulatory proteins, as well as of misfolded or damaged polypeptides. Central to this pathway is the posttranslational covalent conjugation of ubiquitin to other eukaryotic target proteins, which acts as a signal for target protein degradation by the 26S proteasome proteolytic complex. Here, I propose a mechanism by which the expression of a frameshift ubiquitin mutant (termed 'ubiquitin(+1)'), which arises in the ageing human brain as a result of a process known as 'molecular misreading', could lead to a progressive age-dependent inhibition of the 26S proteasome. Further, I propose that such an inhibition contributes directly to Alzheimer's disease pathogenesis. Copyright 2001 Harcourt Publishers Ltd.
机译:泛素/ 26S蛋白酶体途径催化关键调节蛋白以及错误折叠或损坏的多肽的降解。该途径的中心是泛素与其他真核靶蛋白的翻译后共价缀合,其充当26S蛋白酶体蛋白水解复合物降解靶蛋白的信号。在此,我提出了一种机制,通过这种机制,移码后的泛素突变体(称为“泛素(+1)”)的表达可能会由于“分子误读”过程而在人脑衰老中产生。对26S蛋白酶体的年龄依赖性的进行性抑制。此外,我提出这种抑制作用直接促进阿尔茨海默氏病的发病机理。版权所有2001 Harcourt Publishers Ltd.。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号